Shiga-Like Toxin II Impairs Hepatobiliary Transport of Doxorubicin in Rats by Down-Regulation of Hepatic P Glycoprotein and Multidrug Resistance-Associated Protein Mrp2

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2003-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.47.5.1636-1642.2003PMID 12709333PMCID PMC153315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of the nonimmunosuppressive cyclosporin analog SDZ PSC-833 on colchicine and doxorubicin biliary secretion by the rat in vivo

  2004cited by this paper
• Shiga-Like Toxin II Derived from Escherichia coli O157:H7 Modifies Renal Handling of Levofloxacin in Rats

  2002cited by this paper
• Shiga-like toxin II modifies brain distribution of a P-glycoprotein substrate, doxorubicin, and P-glycoprotein expression in mice.

  2002cited by this paper
• Sinusoidal Efflux of Taurocholate Is Enhanced in Mrp2-Deficient Rat Liver

  2001cited by this paper
• Up‐regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver

  2001cited by this paper
• Endotoxin‐stimulated macrophages decrease bile acid uptake in WIF‐B cells, a rat hepatoma hybrid cell line

  2000cited by this paper
• The role of mdr1a P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice.

  2000cited by this paper
• Retroviral Transfection of Madin-Darby Canine Kidney Cells with Human MDR1 Results in a Major Increase in Globotriaosylceramide and 105- to 106-Fold Increased Cell Sensitivity to Verocytotoxin

  2000cited by this paper
• Characterization of inducible nature of MRP3 in rat liver.

  2000cited by this paper
• Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells.

  1999cited by this paper
• Kupffer cell-mediated down regulation of rat hepatic CMOAT/MRP2 gene expression.

  1999cited by this paper
• The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver*

  1998cited by this paper
• Globotriaosyl ceramide (Gb3) expression in human tumour cells: intracellular trafficking defines a new retrograde transport pathway from the cell surface to the nucleus, which correlates with sensitivity to verotoxin.

  1998cited by this paper
• Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats.

  1998cited by this paper
• Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.

  1998cited by this paper
• Effect of multidrug resistance modulators on the hepatobiliary disposition of doxorubicin in the isolated perfused rat liver.

  1998cited by this paper
• A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells.

  1997cited by this paper
• Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene

  1996cited by this paper
• Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release.

  1996cited by this paper
• Identification of a sister gene to P-glycoprotein.

  1995cited by this paper
• The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1.

  1995cited by this paper
• [Hemolytic-uremic syndrome after verotoxin-producing Escherichia coli infection].

  1995cited by this paper
• Transport studies of doxorubicin in model membranes indicate a difference in passive diffusion across and binding at the outer and inner leaflets of the plasma membrane.

  1994cited by this paper
• Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats.

  1994cited by this paper
• Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages

  1994cited by this paper
• Anti-tumor necrosis factor properties of non-peptide drugs in acute-phase responses.

  1994cited by this paper
• A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome.

  1993cited by this paper
• Cytochrome P450 2B1-mediated one-electron reduction of adriamycin: a study with rat liver microsomes and purified enzymes.

  1993cited by this paper
• Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro

  1993cited by this paper
• Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1.

  1992cited by this paper
• The pathogenic mechanisms of Shiga toxin and the Shiga‐like toxins

  1991cited by this paper
• Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.

  1991cited by this paper
• Effects of cytokines on the liver

  1991cited by this paper
• Mechanisms of resistance of confluent human and rat colon cancer cells to anthracyclines: alteration of drug passive diffusion.

  1990cited by this paper
• Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice

  1989cited by this paper
• Infection by verocytotoxin-producing Escherichia coli

  1989cited by this paper
• Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1

  1988cited by this paper
• Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

  1987cited by this paper
• Metabolism of doxorubicin and epirubicin in adult human hepatocytes in culture.

  1986cited by this paper
• Metabolism of 4'-modified analogs of doxorubicin. unique glucuronidation pathway for 4'-epidoxorubicin.

  1984cited by this paper
• Disposition of 14C-labelled 4′-epidoxorubicin and doxorubicin in the rat

  1984cited by this paper
• Pharmacological studies of ricin in mice and humans

  1984cited by this paper
• Cytophotometric analysis of the nuclear uptake of adriamycin in in vivo normal mouse liver and kidney cells.

  1982cited by this paper
• Disposition and metabolism of adriamycin in the rat.

  1980cited by this paper
• of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Shiga and Shiga-Like Toxins Shiga and Shiga-Like Toxins

  year unknowncited by this paper

• Genetic polymorphisms of ABCC2 and CBR3 can influence the efficacy and toxicity of doxorubicin therapy in Egyptian patients with non-Hodgkin lymphoma

  2025influential citation
• Association between genetic variants of transmembrane transporters and susceptibility to anthracycline‐induced cardiotoxicity: Current understanding and existing evidence

  2023cites this paper
• Catalpol alleviates adriamycin‐induced nephropathy by activating the SIRT1 signalling pathway in vivo and in vitro

  2019cites this paper
• Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer

  2018cites this paper
• Regulation of Drug Transporters by Inflammation

  2017cites this paper
• Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review

  2016cites this paper
• Infection-mediated Modulation of Drug Transporters in Pregnancy; Implications for Fetal Drug Exposure

  2015cites this paper
• Species Differences in Biliary Clearance and Possible Relevance of Hepatic Uptake and Efflux Transporters Involvement

  2013cites this paper
• Genetic susceptibility to anthracycline‐related congestive heart failure in survivors of haematopoietic cell transplantation

  2013cites this paper
• Effects of 17α-ethynylestradiol-induced cholestasis on the pharmacokinetics of doxorubicin in rats: reduced biliary excretion and hepatic metabolism of doxorubicin

  2013influential citation
• Impact of Diabetes on Drug Disposition Mechanisms in Pregnancy

  2012cites this paper
• Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response

  2012cites this paper
• Drug-Cytokine Interactions

  2011cites this paper
• Expression and function of p-glycoprotein in normal tissues: effect on pharmacokinetics.

  2010cites this paper
• Regulation of hepatic ABCC transporters by xenobiotics and in disease states

  2010cites this paper
• Effects of lipopolysaccharide on P-glycoprotein expression and activity in the liver and kidneys.

  2010cites this paper
• Effect of methotrexate treatment on expression levels of organic anion transporter polypeptide 2, P-glycoprotein and bile salt export pump in rats.

  2009cites this paper
• Alteration of methotrexate biliary and renal elimination during extrahepatic and intrahepatic cholestasis in rats.

  2009cites this paper
• Impact of Acute Streptozotocin‐Induced Diabetes on ABC Transporter Expression in Rats

  2009cites this paper
• Drug Transporters in Health and Disease

  2009cites this paper
• P-glycoprotein function and expression during obstructive cholestasis in rats

  2008cites this paper
• Involvement of multidrug resistance-associated protein 2 (ABCC2/Mrp2) in biliary excretion of micafungin in rats.

  2008cites this paper
• Regulation of drug transporters during infection and inflammation.

  2007cites this paper
• Genotyping the risk of anthracycline-induced cardiotoxicity

  2007cites this paper
• Involvement of the Drug Transporters P Glycoprotein and Multidrug Resistance-Associated Protein Mrp2 in Telithromycin Transport

  2006cites this paper
• Gender-related differences in expression and function of hepatic P-glycoprotein and multidrug resistance-associated protein (Mrp2) in rats.

  2006cites this paper
• Effect of Shiga-like toxin II from Escherichia coli O157:H7 on intestinal clearance of norfloxacin in rats.

  2006cites this paper
• IMPACT OF ENDOTOXIN-INDUCED CHANGES IN P-GLYCOPROTEIN EXPRESSION ON DISPOSITION OF DOXORUBICIN IN MICE

  2005cites this paper
• Role of tumor necrosis factor-alpha in down-regulation of hepatic cytochrome P450 and P-glycoprotein by endotoxin.

  2005cites this paper
• NAD(P)H Oxidase and Multidrug Resistance Protein Genetic Polymorphisms Are Associated With Doxorubicin-Induced Cardiotoxicity

  2005cites this paper
• Down-regulation of cytochrome P450 proteins and its activities by Shiga-like toxin II from Escherichia coli O157:H7.

  2004cites this paper
• Azithromycin reverses anticancer drug resistance and modifies hepatobiliary excretion of doxorubicin in rats.

  2004cites this paper
• Possible involvement of P-glycoprotein in renal excretion of pazufloxacin in rats.

  2004cites this paper